Product Code: ETC6185060 | Publication Date: Sep 2024 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The mice model market in Australia plays a vital role in biomedical research and pharmaceutical testing. With a strong research infrastructure and a focus on innovation, Australia is increasingly utilizing genetically modified and humanized mice models to study diseases and develop new treatments. The market is supported by academic institutions, government-funded research organizations, and biotech companies. Ethical considerations and advancements in CRISPR and gene-editing technologies are reshaping the landscape of laboratory animal research.
Australias mice model market is advancing due to increased investment in biomedical research and drug discovery. Genetically modified mice models are gaining traction for studying complex diseases like cancer and neurodegenerative disorders. The market is also benefitting from international collaborations with universities and research institutes, enhancing the scope of translational and preclinical research.
The Mice model market in Australia faces challenges related to the increasing demand for personalized and tailored models in the research and development of vaccines, drugs, and other therapeutic treatments. However, there is a lack of standardization in Mice models used across different industries, which makes it difficult for researchers to compare results across studies. Moreover, the high cost associated with maintaining Mice populations and the ethical concerns related to animal testing remain persistent challenges. The regulatory framework around the use of Mice models in medical research continues to evolve, adding an additional layer of complexity for businesses operating in this space.
With pharmaceutical research and biotech thriving in Australia, investments in mice model suppliers and preclinical research labs can be rewarding. Supporting ventures focused on personalized and genetically engineered models can yield long-term gains. Theres also potential in services that cater to regulatory-compliant breeding and animal welfare-focused housing facilities.
The government policies related to the Mice model market in Australia are largely shaped by regulations on animal research and the ethical use of animal models. The Australian government enforces strict guidelines on the use of animal models in scientific research, such as those outlined by the National Health and Medical Research Council (NHMRC). These guidelines ensure that Mice models are used humanely and only when necessary for scientific advancement. Additionally, the government provides funding for research that uses Mice models through various research grants. However, ethical concerns about animal testing and increasing pressure from animal rights groups can create challenges for researchers and businesses in this space, influencing how these models are developed and used.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Mice Model Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Mice Model Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Mice Model Market - Industry Life Cycle |
3.4 Australia Mice Model Market - Porter's Five Forces |
3.5 Australia Mice Model Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Australia Mice Model Market Revenues & Volume Share, By Specialty, 2021 & 2031F |
4 Australia Mice Model Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Australia Mice Model Market Trends |
6 Australia Mice Model Market, By Types |
6.1 Australia Mice Model Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Australia Mice Model Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Australia Mice Model Market Revenues & Volume, By Transgenic Mice Model, 2021- 2031F |
6.1.4 Australia Mice Model Market Revenues & Volume, By Hybrid / Congenic Mice Model, 2021- 2031F |
6.1.5 Australia Mice Model Market Revenues & Volume, By Knockout Mice Model, 2021- 2031F |
6.2 Australia Mice Model Market, By Specialty |
6.2.1 Overview and Analysis |
6.2.2 Australia Mice Model Market Revenues & Volume, By Immunology, 2021- 2031F |
6.2.3 Australia Mice Model Market Revenues & Volume, By Central Nervous System, 2021- 2031F |
6.2.4 Australia Mice Model Market Revenues & Volume, By Oncology, 2021- 2031F |
6.2.5 Australia Mice Model Market Revenues & Volume, By Cardiovascular, 2021- 2031F |
6.2.6 Australia Mice Model Market Revenues & Volume, By Diabetes, 2021- 2031F |
6.2.7 Australia Mice Model Market Revenues & Volume, By Metabolism & Regulation, 2021- 2031F |
7 Australia Mice Model Market Import-Export Trade Statistics |
7.1 Australia Mice Model Market Export to Major Countries |
7.2 Australia Mice Model Market Imports from Major Countries |
8 Australia Mice Model Market Key Performance Indicators |
9 Australia Mice Model Market - Opportunity Assessment |
9.1 Australia Mice Model Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Australia Mice Model Market Opportunity Assessment, By Specialty, 2021 & 2031F |
10 Australia Mice Model Market - Competitive Landscape |
10.1 Australia Mice Model Market Revenue Share, By Companies, 2024 |
10.2 Australia Mice Model Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |